(Q27077865)
Statements
526.305624±0 dalton
1 reference
GSK126 (English)
3 October 2016
C₃₁H₃₈N₆O₂
1 reference
GSK126 (English)
20 November 2016
CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C
1 reference
GSK126 (English)
20 November 2016
CC[C@H](C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C
1 reference
GSK126 (English)
20 November 2016
Identifiers
1 reference
GSK126 (English)
20 November 2016
2 references
GSK126 (English)
20 November 2016
2 references
gsk-2816126 (English)
20 November 2016
1 reference
1-[(2S)-2-Butanyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide (English)
20 November 2016
2 references
GSK126 (English)
20 November 2016
2 references
1 reference
CHEMBL3287735 (English)
20 November 2016
1 reference
GSK126 (English)
20 November 2016
2 references
gsk-2816126 (English)
20 November 2016